↓ Skip to main content

Cochrane Database of Systematic Reviews

Chlorpromazine versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

blogs
2 blogs
twitter
24 X users
peer_reviews
1 peer review site
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
3 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
392 Mendeley
Title
Chlorpromazine versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd000284.pub3
Pubmed ID
Authors

Clive E Adams, George A Awad, John Rathbone, Ben Thornley, Karla Soares‐Weiser

Abstract

Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 392 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Unknown 389 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 65 17%
Researcher 49 13%
Student > Bachelor 47 12%
Student > Ph. D. Student 41 10%
Student > Doctoral Student 26 7%
Other 65 17%
Unknown 99 25%
Readers by discipline Count As %
Medicine and Dentistry 107 27%
Psychology 63 16%
Nursing and Health Professions 32 8%
Social Sciences 21 5%
Pharmacology, Toxicology and Pharmaceutical Science 14 4%
Other 51 13%
Unknown 104 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#1,397,338
of 26,106,397 outputs
Outputs from Cochrane database of systematic reviews
#2,816
of 13,186 outputs
Outputs of similar age
#14,831
of 322,314 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 235 outputs
Altmetric has tracked 26,106,397 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,186 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,314 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.